Martinez, Fernando J

Publications

Sort by

Co-Author Network

selected publications

Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Disparities in Guideline Concordant Statin Treatment in Individuals with Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary diseases (Miami, Fla.). 2023 Academic Article GET IT
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Respiratory Health and Cities. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Discriminative Accuracy of the CAPTURE Tool for Identifying COPD-Reply. JAMA. 2023 Letter GET IT
Radiomic Feature Spatially Characterizes the Transition of Normal Lung Parenchyma to Small Airways Disease in COPD. medRxiv : the preprint server for health sciences. 2023 Article GET IT
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans. Thorax. 2023 Academic Article GET IT
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Times cited: 1
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists. Clinical research in cardiology : official journal of the German Cardiac Society. 2023 Review GET IT
Prognostic and predictive markers of systemic sclerosis-interstitial lung disease in a clinical trial and long-term observational cohort. Rheumatology (Oxford, England). 2023 Academic Article GET IT
A blood and bronchoalveolar lavage protein signature of rapid FEV₁ decline in smoking-associated COPD. Scientific reports. 2023 Academic Article GET IT
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History. Chronic obstructive pulmonary diseases (Miami, Fla.). 2023 Academic Article GET IT
Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons. Chronic obstructive pulmonary diseases (Miami, Fla.). 2023 Academic Article GET IT
Air pollution and COPD: GOLD 2023 committee report. The European respiratory journal. 2023 Review GET IT
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis. JAMA. 2023 Editorial Article GET IT
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford, England). 2023 Academic Article GET IT
AJRCCM: Strength in Breadth. American journal of respiratory and critical care medicine. 2023 Editorial Article GET IT
A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Times cited: 1
Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV₁ decline: results from COPDGene and SPIROMICS. Frontiers in physiology. 2023 Academic Article GET IT
Times cited: 11
Idiopathic pulmonary fibrosis: state of the art for 2023. The European respiratory journal. 2023 Academic Article GET IT
Times cited: 1
High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis. International journal of chronic obstructive pulmonary disease. 2023 Review GET IT
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. American journal of respiratory and critical care medicine. 2023 Academic Article GET IT
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. The European respiratory journal. 2023 Academic Article GET IT
Times cited: 11
Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge Evidence and Practice Gaps. Annals of the American Thoracic Society. 2023 Academic Article GET IT
Introducing "Viewpoint: Turning the Air Blue". American journal of respiratory and critical care medicine. 2023 Editorial Article GET IT
Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies. Journal of asthma and allergy. 2023 Academic Article GET IT
Times cited: 133
Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nature communications. 2023 Academic Article GET IT
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Respirology (Carlton, Vic.). 2023 Academic Article GET IT
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Archivos de bronconeumologia. 2023 Academic Article GET IT
Times cited: 2
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. JAMA. 2023 Academic Article GET IT
Times cited: 2
Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study. The Lancet. Digital health. 2023 Academic Article GET IT
Times cited: 3
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial. Chronic obstructive pulmonary diseases (Miami, Fla.). 2023 Academic Article GET IT
PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population. Journal of health economics and outcomes research. 2023 Academic Article GET IT
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respiratory research. 2023 Academic Article GET IT
Times cited: 3
Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. The European respiratory journal. 2022 Academic Article GET IT
Times cited: 2
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial. BMC pulmonary medicine. 2022 Academic Article GET IT
Times cited: 1
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS. International journal of chronic obstructive pulmonary disease. 2022 Academic Article GET IT
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 29
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 7
The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis. Annals of the American Thoracic Society. 2022 Academic Article GET IT
Times cited: 4
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2022 Academic Article GET IT
Times cited: 1
Pharmacotherapy and Mortality in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 1
Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS. Respiratory research. 2022 Academic Article GET IT
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis. Respiratory medicine. 2022 Academic Article GET IT
Times cited: 1
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort. Chest. 2022 Academic Article GET IT
Times cited: 1
A Phase IIb Randomized Clinical Study of an Anti-α_vβ₆ Monoclonal Antibody in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 5
Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry. American journal of respiratory and critical care medicine. 2022 Letter GET IT
Times cited: 3
Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 2022 Academic Article GET IT
Times cited: 3
Screening for idiopathic pulmonary fibrosis using comorbidity signatures in electronic health records. Nature medicine. 2022 Academic Article GET IT
Times cited: 1
Effect of marijuana smoking on lung function change in older ever tobacco smokers. The European respiratory journal. 2022 Letter GET IT
Times cited: 1
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial. Journal of the American Heart Association. 2022 Academic Article GET IT
Times cited: 3
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. The New England journal of medicine. 2022 Academic Article GET IT
Times cited: 18
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 4
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. The Lancet. Respiratory medicine. 2022 Review GET IT
Times cited: 5
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial. Respirology (Carlton, Vic.). 2022 Academic Article GET IT
Times cited: 2
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 9
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 19
Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity. Sleep. 2022 Academic Article GET IT
Times cited: 1
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 12
Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis. Thorax. 2022 Academic Article GET IT
Times cited: 2
Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians. Chronic obstructive pulmonary diseases (Miami, Fla.). 2022 Academic Article GET IT
Times cited: 3
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial. International journal of chronic obstructive pulmonary disease. 2022 Academic Article GET IT
Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2022 Letter GET IT
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. American journal of respiratory and critical care medicine. 2022 Review GET IT
Times cited: 18
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials. American journal of respiratory and critical care medicine. 2022 Review GET IT
Times cited: 8
Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 8
Transbronchial Lung Cryobiopsy in Patients with Interstitial Lung Disease: A Systematic Review. Annals of the American Thoracic Society. 2022 Review GET IT
Times cited: 14
Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts. Chest. 2022 Academic Article GET IT
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. 2022 GET IT
Times cited: 295
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial). American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 5
Use of a Genomic Classifier in Patients with Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society. 2022 Review GET IT
Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument. Chronic obstructive pulmonary diseases (Miami, Fla.). 2022 Academic Article GET IT
Times cited: 1
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort. Chronic obstructive pulmonary diseases (Miami, Fla.). 2022 Academic Article GET IT
Times cited: 8
Assessing mortality differences across acute respiratory failure management strategies in Covid-19. Journal of critical care. 2022 Academic Article GET IT
Times cited: 3
Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study. Respiratory medicine. 2022 Academic Article GET IT
Times cited: 1
Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Respiratory research. 2022 Academic Article GET IT
Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial. Respiratory research. 2022 Academic Article GET IT
Times cited: 9
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR. The Science of the total environment. 2022 Academic Article GET IT
Times cited: 4
Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2022 Review GET IT
Times cited: 9
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 23
Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study. Advances in therapy. 2022 Article GET IT
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases. Respirology (Carlton, Vic.). 2022 Academic Article GET IT
Times cited: 5
Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2022 Academic Article GET IT
Times cited: 13
Comparative Impact of Depressive Symptoms and FEV₁% on Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 2022 Academic Article GET IT
Times cited: 3
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward. American journal of respiratory and critical care medicine. 2022 Review GET IT
Times cited: 38
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial. Chronic obstructive pulmonary diseases (Miami, Fla.). 2022 Academic Article GET IT
Times cited: 3
Screening for Chronic Obstructive Pulmonary Disease: Unmet Needs and Future Considerations. JAMA. 2022 Editorial Article GET IT
Advancing Global Respiratory Health, Sleep, and Critical Care: Editorial from the New American Journal of Respiratory and Critical Care Medicine Team. American journal of respiratory and critical care medicine. 2022 Editorial Article GET IT
Times cited: 1
Predictive modeling of COPD exacerbation rates using baseline risk factors. Therapeutic advances in respiratory disease. 2022 Academic Article GET IT
Times cited: 1
Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease. Respiratory research. 2021 Academic Article GET IT
Times cited: 2
Discordant diagnostic criteria for pneumonia in COPD trials: a review. European respiratory review : an official journal of the European Respiratory Society. 2021 Review GET IT
Times cited: 4
Significance of FEV₃/FEV₆ in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort. Chest. 2021 Academic Article GET IT
Times cited: 6
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice. Arthritis & rheumatology (Hoboken, N.J.). 2021 Review GET IT
Times cited: 35
Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade. Journal of global health. 2021 Academic Article GET IT
Times cited: 13
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial. The European respiratory journal. 2021 Letter GET IT
Times cited: 2
Antimicrobial Therapy and Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis-Reply. JAMA. 2021 Letter GET IT
Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis. Thorax. 2021 Academic Article GET IT
Moving beyond usual interstitial pneumonia to define progressive fibrotic interstitial lung disease. The Lancet. Respiratory medicine. 2021 Academic Article GET IT
Letter to Editor Regarding the OCEAN Study [Letter]. International journal of chronic obstructive pulmonary disease. 2021 Comment GET IT
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 13
Perplexing mortality data from triple therapy trials in COPD - Author's reply. The Lancet. Respiratory medicine. 2021 Letter GET IT
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases. Respiratory medicine. 2021 Review GET IT
Times cited: 16
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. International journal of chronic obstructive pulmonary disease. 2021 Academic Article GET IT
Times cited: 5
Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States. Respiratory research. 2021 Academic Article GET IT
Times cited: 4
Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19. Scientific reports. 2021 Academic Article GET IT
Times cited: 13
Polycythemia is Associated with Lower Incidence of Severe COPD Exacerbations in the SPIROMICS Study. Chronic obstructive pulmonary diseases (Miami, Fla.). 2021 Academic Article GET IT
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial. ERJ open research. 2021 Academic Article GET IT
Times cited: 83
Reversal of emphysema by restoration of pulmonary endothelial cells. The Journal of experimental medicine. 2021 Academic Article GET IT
Times cited: 20
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 15
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 14
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial. Pulmonary therapy. 2021 Academic Article GET IT
Times cited: 54
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. Respiratory medicine. 2021 Academic Article GET IT
Times cited: 6
Future concepts in bronchodilation for COPD: dual- versus monotherapy. European respiratory review : an official journal of the European Respiratory Society. 2021 Review GET IT
Times cited: 6
Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). International journal of chronic obstructive pulmonary disease. 2021 Academic Article GET IT
Times cited: 7
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. The Lancet. Respiratory medicine. 2021 Academic Article GET IT
Times cited: 46
The Challenges of Defining Early Chronic Obstructive Pulmonary Disease in the General Population. American journal of respiratory and critical care medicine. 2021 Editorial Article GET IT
Times cited: 1
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA. 2021 Academic Article GET IT
Times cited: 25
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT. Annals of the American Thoracic Society. 2021 Academic Article GET IT
Times cited: 13
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations. Respiratory research. 2021 Academic Article GET IT
Times cited: 6
Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?. Chronic obstructive pulmonary diseases (Miami, Fla.). 2021 Academic Article GET IT
Times cited: 3
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort. Respiratory research. 2021 Academic Article GET IT
Times cited: 8
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium. Genome medicine. 2021 Academic Article GET IT
Times cited: 15
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 22
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 36
Reply to López-Campos et al. and to Rogliani and Calzetta. American journal of respiratory and critical care medicine. 2021 Letter GET IT
Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect. American journal of respiratory and critical care medicine. 2021 Letter GET IT
Letter to editor - a response to: 'efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review'. Expert opinion on pharmacotherapy. 2021 Letter GET IT
Times cited: 1
The influence of social support on COPD outcomes mediated by depression. PloS one. 2021 Academic Article GET IT
Times cited: 3
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 28
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis. ERJ open research. 2021 Academic Article GET IT
Times cited: 631
Latent traits of lung tissue patterns in former smokers derived by dual channel deep learning in computed tomography images. Scientific reports. 2021 Academic Article GET IT
Times cited: 6
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 78
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2021 Academic Article GET IT
Times cited: 9
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 14
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. NPJ biofilms and microbiomes. 2021 Academic Article GET IT
Times cited: 22
Ratio of FEV₁/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function. Chest. 2021 Academic Article GET IT
Times cited: 5
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS. International journal of chronic obstructive pulmonary disease. 2021 Academic Article GET IT
Times cited: 9
Natural history and mechanisms of COPD. Respirology (Carlton, Vic.). 2021 Review GET IT
Times cited: 30
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. American journal of respiratory and critical care medicine. 2021 Academic Article GET IT
Times cited: 41
Establishing content-validity of a disease-specific health-related quality of life instrument for patients with chronic hypersensitivity pneumonitis. Journal of patient-reported outcomes. 2021 Academic Article GET IT
Times cited: 111
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2021 Review GET IT
Times cited: 273
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial. Therapeutic advances in respiratory disease. 2021 Academic Article GET IT
Times cited: 5
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. Chronic obstructive pulmonary diseases (Miami, Fla.). 2021 Academic Article GET IT
Times cited: 2
Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study. Chronic obstructive pulmonary diseases (Miami, Fla.). 2021 Academic Article GET IT
Times cited: 8
Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2021 Letter GET IT
Reply to: 'evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies'. Expert review of respiratory medicine. 2020 Letter GET IT
Times cited: 2
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial. Chest. 2020 Academic Article GET IT
Times cited: 19
Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment. Respiratory medicine. 2020 Academic Article GET IT
Times cited: 3
Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects. Scientific reports. 2020 Academic Article GET IT
Times cited: 6
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial. Pulmonary therapy. 2020 Academic Article GET IT
Times cited: 46
One More Time: The Impact of Inhaled Corticosteroid Withdrawal on IMPACT. American journal of respiratory and critical care medicine. 2020 Editorial Article GET IT
Times cited: 2
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial. American journal of respiratory and critical care medicine. 2020 Academic Article GET IT
Times cited: 24
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort. International journal of chronic obstructive pulmonary disease. 2020 Academic Article GET IT
Times cited: 7
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2020 Academic Article GET IT
Times cited: 5
Triple Inhaled Therapy in COPD. Reply. The New England journal of medicine. 2020 Letter GET IT
Times cited: 1
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2020 Review GET IT
Times cited: 44
Host, Gender, and Early-Life Factors as Risks for Chronic Obstructive Pulmonary Disease. Clinics in chest medicine. 2020 Review GET IT
Times cited: 1
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. The Lancet. Respiratory medicine. 2020 Conference Paper GET IT
Times cited: 150
Respiratory Mechanics and Gas Exchange in COVID-19-associated Respiratory Failure. Annals of the American Thoracic Society. 2020 Letter GET IT
Times cited: 81
Update in Interstitial Lung Disease 2019. American journal of respiratory and critical care medicine. 2020 Review GET IT
Times cited: 5
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort. International journal of chronic obstructive pulmonary disease. 2020 Academic Article GET IT
Times cited: 1
Identification of a unique temporal signature in blood and BAL associated with IPF progression. Scientific reports. 2020 Academic Article GET IT
Times cited: 8
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial. Respiratory research. 2020 Academic Article GET IT
Times cited: 9
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study. Advances in therapy. 2020 Academic Article GET IT
Times cited: 6
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax. 2020 Academic Article GET IT
Times cited: 16
Obesity and COVID-19 in New York City: A Retrospective Cohort Study. Annals of internal medicine. 2020 Letter GET IT
Times cited: 59
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS. Scientific reports. 2020 Academic Article GET IT
Times cited: 10
The natural history of progressive fibrosing interstitial lung diseases. The European respiratory journal. 2020 Academic Article GET IT
Times cited: 121
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. The New England journal of medicine. 2020 Academic Article GET IT
Times cited: 233
Life at the Editorial "COVID Frontline". The American Thoracic Society Journal Family. American journal of respiratory and critical care medicine. 2020 Editorial Article GET IT
Times cited: 7
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2020 Academic Article GET IT
Times cited: 106
Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults. JAMA. 2020 Academic Article GET IT
Times cited: 61
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial. Respiratory research. 2020 Academic Article GET IT
Times cited: 8
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. Cell. 2020 Academic Article GET IT
Times cited: 841
Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies. Respiratory research. 2020 Review GET IT
Times cited: 3
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene. Chest. 2020 Review GET IT
Times cited: 16
The effect of exacerbation history on outcomes in the IMPACT trial. The European respiratory journal. 2020 Academic Article GET IT
Times cited: 3
FEV₁ is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease. International journal of chronic obstructive pulmonary disease. 2020 Academic Article GET IT
Times cited: 23
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis. Chest. 2020 Review GET IT
Times cited: 15
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial. American journal of respiratory and critical care medicine. 2020 Letter GET IT
Times cited: 7
Severe Covid-19. The New England journal of medicine. 2020 Review GET IT
Times cited: 877
A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease. Chest. 2020 Letter GET IT
Times cited: 1
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. American journal of respiratory and critical care medicine. 2020 Academic Article GET IT
Times cited: 142
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD. ERJ open research. 2020 Academic Article GET IT
Times cited: 214
Clinical Characteristics of Covid-19 in New York City. The New England journal of medicine. 2020 Letter GET IT
Times cited: 1479
Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial. Chest. 2020 Academic Article GET IT
Times cited: 6
Reply to Janssen and Wouters: Loss of Alveolar Attachments as a Pathomechanistic Link between Small Airway Disease and Emphysema. American journal of respiratory and critical care medicine. 2020 Letter GET IT
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial. Respiratory research. 2020 Academic Article GET IT
Times cited: 15
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. American journal of respiratory and critical care medicine. 2020 Academic Article GET IT
Times cited: 32
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort. JCI insight. 2020 Academic Article GET IT
Times cited: 24
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD. Respiratory research. 2020 Academic Article GET IT
Times cited: 18
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease. BMJ open respiratory research. 2020 Academic Article GET IT
Times cited: 49
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies. International journal of chronic obstructive pulmonary disease. 2020 Academic Article GET IT
Times cited: 3
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers. JAMA internal medicine. 2020 Academic Article GET IT
Times cited: 44
POINT: Can Screening for COPD Improve Outcomes? Yes. Chest. 2020 Editorial Article GET IT
Times cited: 13
Rebuttal From Drs Yawn and Martinez. Chest. 2020 Editorial Article GET IT
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. International journal of chronic obstructive pulmonary disease. 2019 Academic Article GET IT
Times cited: 8
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE). American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 39
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2019 Letter GET IT
Times cited: 16
Relationship between diffusion capacity and small airway abnormality in COPDGene. Respiratory research. 2019 Letter GET IT
Times cited: 18
COPDGene^® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary diseases (Miami, Fla.). 2019 Academic Article GET IT
Times cited: 112
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 47
Metoprolol for the Prevention of Acute Exacerbations of COPD. The New England journal of medicine. 2019 Academic Article GET IT
Times cited: 84
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes. Scientific reports. 2019 Academic Article GET IT
Times cited: 10
Risk factors for disease progression in idiopathic pulmonary fibrosis. Thorax. 2019 Academic Article GET IT
Times cited: 17
Can Macrolide Antibiotics Prevent Hospital Readmissions?. American journal of respiratory and critical care medicine. 2019 Editorial Article GET IT
Times cited: 3
A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 30
Misinterpretation of time-to-first event curves can lead to inappropriate treatment. The European respiratory journal. 2019 Letter GET IT
Times cited: 1
Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 86
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol. Respiratory medicine. 2019 Academic Article GET IT
Times cited: 21
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. The Lancet. Respiratory medicine. 2019 Academic Article GET IT
Times cited: 86
Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV₁/FVC. Respiratory medicine. 2019 Review GET IT
Times cited: 24
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study. Scientific reports. 2019 Academic Article GET IT
Times cited: 15
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 70
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 6
Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS). Respiratory research. 2019 Academic Article GET IT
Times cited: 20
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. The Lancet. Respiratory medicine. 2019 Academic Article GET IT
Times cited: 133
Regional differences in rate of FEV₁ decline in COPD: lessons from SUMMIT. The European respiratory journal. 2019 Letter GET IT
Times cited: 2
Objectively Measured Chronic Lung Injury on Chest CT. Chest. 2019 Academic Article GET IT
Times cited: 6
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. The European respiratory journal. 2019 Review GET IT
Times cited: 987
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial. BMJ open respiratory research. 2019 Academic Article GET IT
Times cited: 32
Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 8
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2019 Academic Article GET IT
Times cited: 148
Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease. Results from the SPIROMICS Bronchoscopy Substudy. Annals of the American Thoracic Society. 2019 Academic Article GET IT
Times cited: 11
The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ open research. 2019 Academic Article GET IT
Times cited: 40
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study. The Lancet. Respiratory medicine. 2019 Academic Article GET IT
Times cited: 86
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. The Lancet. Respiratory medicine. 2019 Academic Article GET IT
Times cited: 112
Diagnosis and management of asthma, COPD and asthma-COPD overlap among primary care physicians and respiratory/allergy specialists: A global survey. The clinical respiratory journal. 2019 Academic Article GET IT
Times cited: 10
Effect of daily azithromycin therapy and adherence on readmission risk in COPD. The European respiratory journal. 2019 Letter GET IT
Times cited: 6
Inference of Cellular Immune Environments in Sputum and Peripheral Blood Associated with Acute Exacerbations of COPD. Cellular and molecular bioengineering. 2019 Academic Article GET IT
Times cited: 90
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT. ERJ open research. 2019 Academic Article GET IT
Times cited: 3
Reprint of: Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers. Academic radiology. 2019 Academic Article GET IT
Times cited: 9
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS. Annals of the American Thoracic Society. 2019 Academic Article GET IT
Times cited: 25
Why Does an Aging Smoker's Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?. American journal of respiratory and critical care medicine. 2019 Review GET IT
Times cited: 17
Pulmonary hypertension in chronic lung disease and hypoxia. The European respiratory journal. 2019 Review GET IT
Times cited: 320
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS. Chest. 2019 Academic Article GET IT
Times cited: 14
ILD: Upcoming Themed Issue. American journal of respiratory and critical care medicine. 2019 Editorial Article GET IT
Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene® Cohort. Chronic obstructive pulmonary diseases (Miami, Fla.). 2019 Academic Article GET IT
Times cited: 19
Effects of baseline symptom burden on treatment response in COPD. International journal of chronic obstructive pulmonary disease. 2019 Academic Article GET IT
Times cited: 7
Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. American journal of respiratory and critical care medicine. 2019 Editorial Article GET IT
Times cited: 84
Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee. Annals of the American Thoracic Society. 2019 Academic Article GET IT
Times cited: 9
Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort. Respiratory research. 2018 Academic Article GET IT
Times cited: 13
An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 56
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction. Respiratory research. 2018 Academic Article GET IT
Times cited: 9
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 48
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene. JCI insight. 2018 Academic Article GET IT
Times cited: 27
Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes. Chest. 2018 Academic Article GET IT
Times cited: 4
Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis, Prognosis, and Treatment. Chest. 2018 Academic Article GET IT
Times cited: 10
Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. The Lancet. Haematology. 2018 Academic Article GET IT
Times cited: 16
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory. Chest. 2018 Academic Article GET IT
Times cited: 116
Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). Respiratory research. 2018 Academic Article GET IT
Times cited: 18
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. The Lancet. Respiratory medicine. 2018 Academic Article GET IT
Times cited: 215
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. The New England journal of medicine. 2018 Academic Article GET IT
Times cited: 167
Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 19
An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos. The Journal of allergy and clinical immunology. 2018 Review GET IT
Times cited: 25
Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease. Journal of the American College of Cardiology. 2018 Academic Article GET IT
Times cited: 38
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. European heart journal. 2018 Academic Article GET IT
Times cited: 23
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. 2018 GET IT
Times cited: 2052
Idiopathic Pulmonary Fibrosis. The New England journal of medicine. 2018 Letter GET IT
Times cited: 5
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis. The European respiratory journal. 2018 Academic Article GET IT
Times cited: 44
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. The Lancet. Respiratory medicine. 2018 Academic Article GET IT
Times cited: 90
Clinical Approach to the Therapy of Asthma-COPD Overlap. Chest. 2018 Review GET IT
Times cited: 36
Genome-wide association study of lung function and clinical implication in heavy smokers. BMC medical genetics. 2018 Academic Article GET IT
Times cited: 22
Precision medicine in COPD: where are we and where do we need to go?. European respiratory review : an official journal of the European Respiratory Society. 2018 Review GET IT
Times cited: 47
Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers. Academic radiology. 2018 Academic Article GET IT
Times cited: 39
Association between Emphysema and Chronic Obstructive Pulmonary Disease Outcomes in the COPDGene and SPIROMICS Cohorts: A Post Hoc Analysis of Two Clinical Trials. American journal of respiratory and critical care medicine. 2018 Letter GET IT
Times cited: 23
Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD. Chest. 2018 Academic Article GET IT
Times cited: 16
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 134
Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Annals of the American Thoracic Society. 2018 Academic Article GET IT
Times cited: 26
Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial. American journal of respiratory and critical care medicine. 2018 Letter GET IT
Times cited: 2
Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement. American journal of respiratory and critical care medicine. 2018 Letter GET IT
Update in Chronic Obstructive Pulmonary Disease 2017. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 3
Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?. International journal of chronic obstructive pulmonary disease. 2018 Academic Article GET IT
Times cited: 8
Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology. 2018 Academic Article GET IT
Times cited: 23
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. Respiratory medicine. 2018 Academic Article GET IT
Times cited: 11
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS. Annals of the American Thoracic Society. 2018 Academic Article GET IT
Times cited: 23
Chronic obstructive pulmonary disease subpopulations and phenotyping. The Journal of allergy and clinical immunology. 2018 Review GET IT
Times cited: 32
Idiopathic Pulmonary Fibrosis. The New England journal of medicine. 2018 Review GET IT
Times cited: 821
Efficacy and safety profile of xanthines in COPD: a network meta-analysis. European respiratory review : an official journal of the European Respiratory Society. 2018 Review GET IT
Times cited: 37
Intensifying Long-Acting β-Agonist/Corticosteroid Therapy at Acute Exacerbations of Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2018 Editorial Article GET IT
Times cited: 1
Time to Understand the Infrequency of the Frequent Exacerbator Phenotype in COPD. Chest. 2018 Editorial Article GET IT
Times cited: 5
β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT. Annals of the American Thoracic Society. 2018 Academic Article GET IT
Times cited: 19
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. The New England journal of medicine. 2018 Academic Article GET IT
Times cited: 686
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS. PloS one. 2018 Academic Article GET IT
Times cited: 22
Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps. Current opinion in pulmonary medicine. 2018 Review GET IT
Times cited: 20
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD. Respiratory research. 2018 Academic Article GET IT
Times cited: 25
Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers. Thorax. 2018 Academic Article GET IT
Times cited: 8
Cigarette smoking and response to inhaled corticosteroids in COPD. The European respiratory journal. 2018 Letter GET IT
Times cited: 22
Human airway branch variation and chronic obstructive pulmonary disease. Proceedings of the National Academy of Sciences of the United States of America. 2018 Academic Article GET IT
Times cited: 62
Reply to Londhe et al.: CAPTURE: A Screening Tool for Chronic Obstructive Pulmonary Disease or Obstructive Airway Disease?. American journal of respiratory and critical care medicine. 2018 Comment GET IT
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. American journal of respiratory and critical care medicine. 2018 Academic Article GET IT
Times cited: 34
The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned. Annals of the American Thoracic Society. 2018 Academic Article GET IT
Times cited: 8
Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nature genetics. 2017 Review GET IT
Times cited: 283
Reply: Improving Care for Patients with Interstitial Lung Disease, Using Machine Learning, Requires Transparency and Reproducibility. Annals of the American Thoracic Society. 2017 Letter GET IT
The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2017 Review GET IT
Times cited: 77
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 128
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. The Lancet. Respiratory medicine. 2017 Academic Article GET IT
Times cited: 172
Differentiation of quantitative CT imaging phenotypes in asthma versus COPD. BMJ open respiratory research. 2017 Academic Article GET IT
Times cited: 664
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning. Annals of the American Thoracic Society. 2017 Academic Article GET IT
Times cited: 71
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis. Chest. 2017 Academic Article GET IT
Times cited: 53
Idiopathic pulmonary fibrosis. Nature reviews. Disease primers. 2017 Review GET IT
Times cited: 571
Variability in objective and subjective measures affects baseline values in studies of patients with COPD. PloS one. 2017 Academic Article GET IT
Times cited: 16
Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go. American journal of respiratory and critical care medicine. 2017 Review GET IT
Times cited: 161
Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort. The Journal of allergy and clinical immunology. 2017 Letter GET IT
Times cited: 6
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients. Respiratory medicine. 2017 Academic Article GET IT
Times cited: 23
Airway Mucin Concentration as a Marker of Chronic Bronchitis. The New England journal of medicine. 2017 Academic Article GET IT
Times cited: 215
A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 27
Correcting Nonpathological Variation in Longitudinal Parametric Response Maps of CT Scans in COPD Subjects: SPIROMICS. Tomography (Ann Arbor, Mich.). 2017 Academic Article GET IT
Times cited: 3
Pitfalls in developing new compounds for idiopathic pulmonary fibrosis. Current opinion in pulmonary medicine. 2017 Review GET IT
Times cited: 2
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. The European respiratory journal. 2017 Academic Article GET IT
Times cited: 55
Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis. Science translational medicine. 2017 Academic Article GET IT
Times cited: 73
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory research. 2017 Academic Article GET IT
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial. Respiratory medicine. 2017 Academic Article GET IT
Times cited: 26
Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD. Chest. 2017 Academic Article GET IT
Times cited: 32
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 96
Effect of roflumilast in patients with severe COPD and a history of hospitalisation. The European respiratory journal. 2017 Letter GET IT
Times cited: 36
Erratum to "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary" [Arch Bronconeumol. 2017;53:128-49]. Archivos de bronconeumologia. 2017 Academic Article GET IT
Times cited: 17
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]. Respiratory medicine. 2017 Academic Article GET IT
Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes. Scientific reports. 2017 Academic Article GET IT
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. The Lancet. Respiratory medicine. 2017 Academic Article GET IT
Times cited: 189
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD). Respiratory research. 2017 Academic Article GET IT
Times cited: 28
Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial. Lung. 2017 Academic Article GET IT
Times cited: 8
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. Respiratory research. 2017 Academic Article GET IT
Times cited: 3
Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ open respiratory research. 2017 Academic Article GET IT
Times cited: 54
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Chest. 2017 Academic Article GET IT
Times cited: 27
AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 3
Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment. Chest. 2017 Academic Article GET IT
Times cited: 9
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Annals of the American Thoracic Society. 2017 Academic Article GET IT
Times cited: 27
Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease. The Journal of allergy and clinical immunology. 2017 Academic Article GET IT
Times cited: 28
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes. Scientific reports. 2017 Academic Article GET IT
Times cited: 36
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk. Heart (British Cardiac Society). 2017 Academic Article GET IT
Times cited: 37
Erratum: Erratum: Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic obstructive pulmonary diseases (Miami, Fla.). 2017 Article GET IT
How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients. Chest. 2017 Academic Article GET IT
Times cited: 3
Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 48
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 80
A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 93
Reply: Not So New. American journal of respiratory and critical care medicine. 2017 Comment GET IT
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Respirology (Carlton, Vic.). 2017 Academic Article GET IT
Times cited: 305
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. The European respiratory journal. 2017 Academic Article GET IT
Times cited: 527
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Archivos de bronconeumologia. 2017 Academic Article GET IT
Times cited: 285
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. 2017 GET IT
Times cited: 2059
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respiratory research. 2017 Academic Article GET IT
Times cited: 18
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 54
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 84
Reply: The New Idiopathic Pulmonary Fibrosis Acute Exacerbations Document: One Step Ahead but Still Suspended in the Air. American journal of respiratory and critical care medicine. 2017 Comment GET IT
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory research. 2017 Academic Article GET IT
Times cited: 23
Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?. American journal of respiratory and critical care medicine. 2017 Academic Article GET IT
Times cited: 39
The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers. Academic radiology. 2016 Academic Article GET IT
Times cited: 28
Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. The Lancet. Respiratory medicine. 2016 Academic Article GET IT
Times cited: 156
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. The Lancet. Respiratory medicine. 2016 Review GET IT
Times cited: 70
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD. Chest. 2016 Academic Article GET IT
Times cited: 88
Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study. Chronic obstructive pulmonary diseases (Miami, Fla.). 2016 Academic Article GET IT
Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus. Chronic obstructive pulmonary diseases (Miami, Fla.). 2016 Academic Article GET IT
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 108
Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?. Respiratory medicine. 2016 Academic Article GET IT
Times cited: 16
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. The New England journal of medicine. 2016 Academic Article GET IT
Times cited: 267
Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 82
The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model. American journal of epidemiology. 2016 Academic Article GET IT
Times cited: 17
SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 160
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD. Respiratory medicine. 2016 Academic Article GET IT
Times cited: 18
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 63
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 91
Pharmacogenetics and interstitial lung disease. Current opinion in pulmonary medicine. 2016 Review GET IT
Times cited: 9
Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. International journal of chronic obstructive pulmonary disease. 2016 Academic Article GET IT
Times cited: 6
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF. PloS one. 2016 Academic Article GET IT
Times cited: 36
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. American journal of respiratory and critical care medicine. 2016 Review GET IT
Times cited: 820
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling. Respiratory medicine. 2016 Academic Article GET IT
Times cited: 41
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. The Lancet. Respiratory medicine. 2016 Academic Article GET IT
Times cited: 622
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD). Health and quality of life outcomes. 2016 Academic Article GET IT
Times cited: 6
Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 240
Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2016 Review GET IT
Times cited: 49
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. The Lancet. Respiratory medicine. 2016 Review GET IT
Times cited: 62
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. The New England journal of medicine. 2016 Academic Article GET IT
Times cited: 441
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet (London, England). 2016 Academic Article GET IT
Times cited: 328
Screening, Case-Finding, and Outcomes for Adults With Unrecognized COPD. JAMA. 2016 Editorial Article GET IT
Times cited: 18
An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research. American journal of respiratory and critical care medicine. 2016 Academic Article GET IT
Times cited: 20
Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort. Thorax. 2016 Academic Article GET IT
Times cited: 271
The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?. Chronic obstructive pulmonary diseases (Miami, Fla.). 2016 Academic Article GET IT
Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline. Chest. 2016 Academic Article GET IT
Times cited: 59
Insight into Best Variables for COPD Case Identification: A Random Forests Analysis. Chronic obstructive pulmonary diseases (Miami, Fla.). 2016 Academic Article GET IT
Preoperative anemia, blood transfusion, and neutrophil-to-lymphocyte ratio in patients with stage i non-small cell lung cancer. Cancer cell & microenvironment. 2016 Academic Article GET IT
Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. Chest. 2015 Academic Article GET IT
Times cited: 29
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine. 2015 Academic Article GET IT
Times cited: 232
Integrative phenotyping framework (iPF): integrative clustering of multiple omics data identifies novel lung disease subphenotypes. BMC genomics. 2015 Academic Article GET IT
Times cited: 58
The Microbiome and the Respiratory Tract. Annual review of physiology. 2015 Review GET IT
Times cited: 493
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab. The European respiratory journal. 2015 Academic Article GET IT
Times cited: 80
The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes. Chest. 2015 Academic Article GET IT
Times cited: 29
Hypersensitivity pneumonitis and antigen identification--An alternate approach. Respiratory medicine. 2015 Academic Article GET IT
Times cited: 39
The Impact of Sources of Variability on Parametric Response Mapping of Lung CT Scans. Tomography (Ann Arbor, Mich.). 2015 Academic Article GET IT
Update in Interstitial Lung Disease 2014. American journal of respiratory and critical care medicine. 2015 Review GET IT
Times cited: 6
Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. The European respiratory journal. 2015 Academic Article GET IT
Times cited: 95
Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood. Respiratory research. 2015 Academic Article GET IT
Times cited: 42
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. 2015 GET IT
Times cited: 1364
Intraalveolar Catecholamines and the Human Lung Microbiome. American journal of respiratory and critical care medicine. 2015 Letter GET IT
Times cited: 30
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. European respiratory review : an official journal of the European Respiratory Society. 2015 Review GET IT
Times cited: 65
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet (London, England). 2015 Review GET IT
Times cited: 181
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials. The European respiratory journal. 2015 Academic Article GET IT
Times cited: 49
Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population. NPJ primary care respiratory medicine. 2015 Academic Article GET IT
Times cited: 12
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. The Lancet. Respiratory medicine. 2015 Academic Article GET IT
Times cited: 59
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2015 Conference Paper GET IT
Times cited: 150
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. The European respiratory journal. 2015 Review GET IT
Times cited: 113
Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3. American journal of respiratory and critical care medicine. 2015 Academic Article GET IT
Times cited: 31
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. Lancet (London, England). 2015 Academic Article GET IT
Times cited: 281
Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies. Chronic obstructive pulmonary diseases (Miami, Fla.). 2015 Academic Article GET IT
Older adults with chronic lung disease report less limitation compared with younger adults with similar lung function impairment. Annals of the American Thoracic Society. 2015 Academic Article GET IT
Times cited: 12
Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Annals of the American Thoracic Society. 2015 Academic Article GET IT
Times cited: 120
Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. Journal of cardiac failure. 2014 Academic Article GET IT
Times cited: 42
Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis. Frontiers of medicine. 2014 Academic Article GET IT
Times cited: 28
A simplified score to quantify comorbidity in COPD. PloS one. 2014 Academic Article GET IT
Times cited: 53
Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS). Academic radiology. 2014 Academic Article GET IT
Times cited: 78
Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis. Chest. 2014 Academic Article GET IT
Times cited: 28
Open-access biorepository for idiopathic pulmonary fibrosis. The way forward. Annals of the American Thoracic Society. 2014 Review GET IT
Times cited: 14
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest. 2014 Academic Article GET IT
Times cited: 65
The role of the microbiome in exacerbations of chronic lung diseases. Lancet (London, England). 2014 Review GET IT
Times cited: 295
Cell-associated bacteria in the human lung microbiome. Microbiome. 2014 Academic Article GET IT
Times cited: 61
Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease. PloS one. 2014 Academic Article GET IT
Times cited: 46
Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. Journal of clinical microbiology. 2014 Academic Article GET IT
Times cited: 99
Smoking-related idiopathic interstitial pneumonia. The European respiratory journal. 2014 Academic Article GET IT
Times cited: 27
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respiratory medicine. 2014 Academic Article GET IT
Times cited: 30
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. American journal of respiratory and critical care medicine. 2014 Academic Article GET IT
Times cited: 131
Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respiratory research. 2014 Academic Article GET IT
Times cited: 56
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. The New England journal of medicine. 2014 Academic Article GET IT
Times cited: 384
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. The New England journal of medicine. 2014 Academic Article GET IT
Times cited: 257
Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PloS one. 2014 Academic Article GET IT
Times cited: 134
Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent. PloS one. 2014 Academic Article GET IT
Times cited: 20
Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. American journal of respiratory cell and molecular biology. 2014 Academic Article GET IT
Times cited: 99
Internet access and use by COPD patients in the National Emphysema/COPD Association Survey. BMC pulmonary medicine. 2014 Academic Article GET IT
Times cited: 24
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. The Lancet. Respiratory medicine. 2014 Academic Article GET IT
Times cited: 280
Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Annals of the American Thoracic Society. 2014 Review GET IT
Times cited: 35
Predicting pulmonary fibrosis disease course from past trends in pulmonary function. Chest. 2014 Academic Article GET IT
Times cited: 96
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. The Lancet. Respiratory medicine. 2014 Academic Article GET IT
Times cited: 140
Response. Chest. 2014 Letter GET IT
Times cited: 1
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. American journal of respiratory and critical care medicine. 2014 Academic Article GET IT
Times cited: 174
Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study. Journal of translational medicine. 2014 Academic Article GET IT
Times cited: 42
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respiratory medicine. 2013 Academic Article GET IT
Times cited: 16
Pulmonary hypertension due to left heart diseases. Journal of the American College of Cardiology. 2013 Review GET IT
Times cited: 498
Pulmonary hypertension in chronic lung diseases. Journal of the American College of Cardiology. 2013 Review GET IT
Times cited: 453
MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays. PloS one. 2013 Academic Article GET IT
Times cited: 130
Significance of the microbiome in chronic obstructive pulmonary disease. Annals of the American Thoracic Society. 2013 Academic Article GET IT
Times cited: 16
The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respiratory medicine. 2013 Academic Article GET IT
Times cited: 61
The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches. American journal of respiratory and critical care medicine. 2013 Editorial Article GET IT
Times cited: 20
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. 2013 GET IT
Times cited: 2677
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2013 Academic Article GET IT
Times cited: 250
Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations. COPD. 2013 Academic Article GET IT
Times cited: 25
Long-acting bronchodilators in COPD: an evolving story. The Lancet. Respiratory medicine. 2013 Comment GET IT
Times cited: 1
Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respiratory research. 2013 Academic Article GET IT
Times cited: 157
Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs. PloS one. 2013 Academic Article GET IT
Times cited: 19
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. The Lancet. Respiratory medicine. 2013 Academic Article GET IT
Times cited: 314
Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials. American journal of respiratory and critical care medicine. 2013 Letter GET IT
Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest. 2013 Academic Article GET IT
Times cited: 170
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Annals of internal medicine. 2013 Academic Article GET IT
Times cited: 400
Efficacy of roflumilast in the COPD frequent exacerbator phenotype. Chest. 2013 Academic Article GET IT
Times cited: 99
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. The Lancet. Respiratory medicine. 2013 Academic Article GET IT
Times cited: 404
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. The Lancet. Respiratory medicine. 2013 Academic Article GET IT
Times cited: 283
Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease. Journal of pain and symptom management. 2013 Academic Article GET IT
Times cited: 30
Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression. Respiratory research. 2013 Academic Article GET IT
Times cited: 26
GOLD COPD categories are not fit for purpose in primary care--authors' reply. The Lancet. Respiratory medicine. 2013 Letter GET IT
Times cited: 4
Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respiratory research. 2013 Academic Article GET IT
Times cited: 54
Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial. Respiratory medicine. 2013 Academic Article GET IT
Times cited: 98
Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. Journal of women's health (2002). 2012 Academic Article GET IT
Times cited: 49
Optimizing the 6-min walk test as a measure of exercise capacity in COPD. Chest. 2012 Academic Article GET IT
Times cited: 29
Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease. 2012 Academic Article GET IT
Times cited: 11
Use of direct gradient analysis to uncover biological hypotheses in 16s survey data and beyond. Scientific reports. 2012 Academic Article GET IT
Times cited: 5
Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A. Thorax. 2012 Academic Article GET IT
Times cited: 65
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nature medicine. 2012 Academic Article GET IT
Times cited: 527
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. American journal of physiology. Lung cellular and molecular physiology. 2012 Academic Article GET IT
Times cited: 198
The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol. The European respiratory journal. 2012 Academic Article GET IT
Times cited: 80
Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomarker insights. 2012 Academic Article GET IT
Times cited: 72
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. The Lancet. Respiratory medicine. 2012 Academic Article GET IT
Times cited: 208
Pulmonary arterial enlargement and acute exacerbations of COPD. The New England journal of medicine. 2012 Academic Article GET IT
Times cited: 362
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest. 2012 Academic Article GET IT
Times cited: 26
Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. American journal of respiratory and critical care medicine. 2012 Academic Article GET IT
Times cited: 460
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine. 2012 Review GET IT
Times cited: 3916
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012 Academic Article GET IT
Times cited: 39
Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMC pulmonary medicine. 2012 Academic Article GET IT
Times cited: 51
Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression. Proceedings of the American Thoracic Society. 2012 Academic Article GET IT
Times cited: 24
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol. International journal of chronic obstructive pulmonary disease. 2012 Academic Article GET IT
Times cited: 47
Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis. Fibrogenesis & tissue repair. 2012 Academic Article GET IT
Times cited: 71
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Academic Article GET IT
Times cited: 50
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. The New England journal of medicine. 2012 Academic Article GET IT
Times cited: 1213
The microbiota in respiratory disease. American journal of respiratory and critical care medicine. 2012 Editorial Article GET IT
Times cited: 10
Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. Journal of medical genetics. 2012 Academic Article GET IT
Times cited: 174
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax. 2012 Academic Article GET IT
Times cited: 101
Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus. American journal of respiratory and critical care medicine. 2012 Academic Article GET IT
Times cited: 81
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. American journal of respiratory and critical care medicine. 2012 Conference Paper GET IT
Times cited: 179
Significance of the microbiome in obstructive lung disease. Thorax. 2012 Review GET IT
Times cited: 171
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD. 2012 Academic Article GET IT
Times cited: 43
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. American journal of respiratory and critical care medicine. 2012 Academic Article GET IT
Times cited: 109
The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery. American journal of respiratory and critical care medicine. 2011 Review GET IT
Times cited: 151
Indacaterol. COPD. 2011 Editorial Article GET IT
Times cited: 2
The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. American journal of respiratory and critical care medicine. 2011 Review GET IT
Times cited: 44
Lifetime risk of COPD: what will the future bring?. Lancet (London, England). 2011 Comment GET IT
Times cited: 12
The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development. Lancet (London, England). 2011 Review GET IT
Times cited: 82
Azithromycin for prevention of exacerbations of COPD. The New England journal of medicine. 2011 Academic Article GET IT
Times cited: 956
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respiratory medicine. 2011 Academic Article GET IT
Times cited: 29
Baseline values and short serial change: a "road map" for a poor early outcome in idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. 2011 Editorial Article GET IT
Times cited: 2
Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2011 Review GET IT
Times cited: 20
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011 Academic Article GET IT
Times cited: 327
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Respiratory medicine. 2011 Academic Article GET IT
Times cited: 34
A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PloS one. 2011 Academic Article GET IT
Times cited: 113
Racial differences in quality of life in patients with COPD. Chest. 2011 Academic Article GET IT
Times cited: 39
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. 2011 Academic Article GET IT
Times cited: 400
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. 2011 GET IT
Times cited: 5510
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PloS one. 2011 Academic Article GET IT
Times cited: 676
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization. COPD. 2011 Academic Article GET IT
Times cited: 29
Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD. Respiratory research. 2011 Review GET IT
Times cited: 233
Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. American journal of respiratory and critical care medicine. 2010 Academic Article GET IT
Times cited: 53
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. The European respiratory journal. 2010 Academic Article GET IT
Times cited: 117
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Science translational medicine. 2010 Academic Article GET IT
Times cited: 116
[Roflumilast: clinical review of a new option for the treatment of inflammation in COPD]. Archivos de bronconeumologia. 2010 Review GET IT
Times cited: 2
Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respiratory research. 2010 Academic Article GET IT
Times cited: 110
Chronic obstructive pulmonary disease phenotypes: the future of COPD. American journal of respiratory and critical care medicine. 2010 Academic Article GET IT
Times cited: 806
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. Journal of immunology (Baltimore, Md. : 1950). 2010 Academic Article GET IT
Times cited: 76
Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2010 Academic Article GET IT
Times cited: 136
Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respiratory research. 2010 Academic Article GET IT
Times cited: 68
Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration; international review of thoracic diseases. 2010 Academic Article GET IT
Times cited: 66
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respiratory medicine. 2010 Academic Article GET IT
Times cited: 57
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respiratory research. 2010 Academic Article GET IT
Times cited: 64
The impact of panic disorder on interoception and dyspnea reports in chronic obstructive pulmonary disease. Biological psychology. 2010 Academic Article GET IT
Times cited: 54
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. International journal of chronic obstructive pulmonary disease. 2010 Academic Article GET IT
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. 2010 Academic Article GET IT
Times cited: 220
Gender influences Health-Related Quality of Life in IPF. Respiratory medicine. 2009 Academic Article GET IT
Times cited: 34
Physiological and computed tomographic predictors of outcome from lung volume reduction surgery. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 40
Clinical significance of radiologic characterizations in COPD. COPD. 2009 Academic Article GET IT
Times cited: 78
Prevalence and clinical correlates of bronchoreversibility in severe emphysema. The European respiratory journal. 2009 Academic Article GET IT
Times cited: 43
Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 136
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 97
Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Primary care respiratory journal : journal of the General Practice Airways Group. 2009 Academic Article GET IT
Times cited: 15
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet (London, England). 2009 Academic Article GET IT
Times cited: 530
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet (London, England). 2009 Academic Article GET IT
Times cited: 698
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nature medicine. 2009 Academic Article GET IT
Times cited: 660
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 77
Mesenchymal cell fate and phenotypes in the pathogenesis of emphysema. COPD. 2009 Review GET IT
Times cited: 13
Integrating health status and survival data: the palliative effect of lung volume reduction surgery. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 27
CT metrics of airway disease and emphysema in severe COPD. Chest. 2009 Academic Article GET IT
Times cited: 83
Focusing on outcomes: making the most of COPD interventions. International journal of chronic obstructive pulmonary disease. 2009 Review GET IT
Times cited: 23
Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. American journal of respiratory and critical care medicine. 2009 Academic Article GET IT
Times cited: 82
Nonmedical therapy for chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2009 Review GET IT
Times cited: 5
Assessment of patients with chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2008 Academic Article GET IT
Times cited: 8
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. 2008 Academic Article GET IT
Times cited: 87
Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. AJR. American journal of roentgenology. 2008 Academic Article GET IT
Times cited: 57
Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest. 2008 Academic Article GET IT
Times cited: 40
TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochemistry and cell biology. 2008 Academic Article GET IT
Times cited: 51
Longitudinal change in the BODE index predicts mortality in severe emphysema. American journal of respiratory and critical care medicine. 2008 Academic Article GET IT
Times cited: 104
Natural history of emphysema. Proceedings of the American Thoracic Society. 2008 Review GET IT
Times cited: 31
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. American journal of respiratory and critical care medicine. 2008 Conference Paper GET IT
Times cited: 483
Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008 Academic Article GET IT
Times cited: 174
Sex differences in physiological progression of idiopathic pulmonary fibrosis. The European respiratory journal. 2008 Academic Article GET IT
Times cited: 64
Outcomes for COPD pharmacological trials: from lung function to biomarkers. The European respiratory journal. 2008 Review GET IT
Times cited: 711
Role of macrolide therapy in chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease. 2008 Review GET IT
Times cited: 98
Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2008 Review GET IT
Times cited: 120
An essential role for fibronectin extra type III domain A in pulmonary fibrosis. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 228
Pulmonary diseases and the heart. Circulation. 2007 Review GET IT
Times cited: 156
Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2007 Review GET IT
Times cited: 18
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Archives of internal medicine. 2007 Academic Article GET IT
Times cited: 142
Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007 Review GET IT
Times cited: 151
Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 63
Exacerbations of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2007 Review GET IT
Times cited: 138
Gender and chronic obstructive pulmonary disease: why it matters. American journal of respiratory and critical care medicine. 2007 Editorial Article GET IT
Times cited: 250
Recent advances in idiopathic pulmonary fibrosis. Chest. 2007 Review GET IT
Times cited: 88
Acute exacerbations of idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine. 2007 Review GET IT
Times cited: 949
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 166
Spirometry utilization for COPD: how do we measure up?. Chest. 2007 Academic Article GET IT
Times cited: 164
Sex differences in severe pulmonary emphysema. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 268
Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. The American journal of pathology. 2007 Academic Article GET IT
Times cited: 71
Genetic determinants of emphysema distribution in the national emphysema treatment trial. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 130
Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 91
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. The Journal of clinical investigation. 2007 Academic Article GET IT
Times cited: 264
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. The European respiratory journal. 2007 Academic Article GET IT
Times cited: 60
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD. 2007 Academic Article GET IT
Times cited: 49
The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis. Chest. 2007 Editorial Article GET IT
Times cited: 21
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?. American journal of respiratory and critical care medicine. 2007 Academic Article GET IT
Times cited: 201
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. International journal of antimicrobial agents. 2007 Academic Article GET IT
Times cited: 26
Lessons from the national emphysema treatment trial. Seminars in thoracic and cardiovascular surgery. 2007 Review GET IT
Times cited: 6
Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there. Chest. 2007 Editorial Article GET IT
Times cited: 21
Surgical patient outcomes after the increased use of bilateral lung transplantation. The Journal of thoracic and cardiovascular surgery. 2006 Academic Article GET IT
Times cited: 16
Nonspecific interstitial pneumonia. Seminars in respiratory and critical care medicine. 2006 Review GET IT
Times cited: 30
Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolution. Journal of thoracic imaging. 2006 Academic Article GET IT
Times cited: 20
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. The Annals of thoracic surgery. 2006 Academic Article GET IT
Times cited: 279
Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2006 Academic Article GET IT
Times cited: 4
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. American journal of respiratory and critical care medicine. 2006 Academic Article GET IT
Times cited: 312
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. 2006 GET IT
Times cited: 934
Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. The American journal of pathology. 2006 Academic Article GET IT
Times cited: 39
Cyclophosphamide for scleroderma lung disease. The New England journal of medicine. 2006 Editorial Article GET IT
Times cited: 41
Pulmonary function testing in idiopathic interstitial pneumonias. Proceedings of the American Thoracic Society. 2006 Review GET IT
Times cited: 111
Update in diffuse parenchymal lung diseases 2005. American journal of respiratory and critical care medicine. 2006 Review GET IT
Times cited: 16
Predictors of mortality in patients with emphysema and severe airflow obstruction. American journal of respiratory and critical care medicine. 2006 Academic Article GET IT
Times cited: 361
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2006 Academic Article GET IT
Times cited: 101
Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease. Expert review of anti-infective therapy. 2006 Review GET IT
Times cited: 38
Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. Journal of clinical pathology. 2006 Academic Article GET IT
Times cited: 34
Idiopathic interstitial pneumonias: usual interstitial pneumonia versus nonspecific interstitial pneumonia. Proceedings of the American Thoracic Society. 2006 Review GET IT
Times cited: 45
Acute exacerbation of chronic bronchitis: expanding short-course therapy. International journal of antimicrobial agents. 2005 Review GET IT
Times cited: 7
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. The American journal of medicine. 2005 Academic Article GET IT
Times cited: 133
Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). American journal of respiratory and critical care medicine. 2005 Academic Article GET IT
Times cited: 177
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis and rheumatism. 2005 Academic Article GET IT
Times cited: 94
Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis. The American journal of medicine. 2005 Review GET IT
Times cited: 23
Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. The American journal of surgical pathology. 2005 Review GET IT
Times cited: 110
The clinical course of patients with idiopathic pulmonary fibrosis. Annals of internal medicine. 2005 Academic Article GET IT
Times cited: 526
Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg. The European respiratory journal. 2005 Academic Article GET IT
Times cited: 43
Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. American journal of respiratory and critical care medicine. 2005 Academic Article GET IT
Times cited: 59
Interstitial lung disease, lung cancer, lung transplantation, pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004. American journal of respiratory and critical care medicine. 2005 Review GET IT
Times cited: 2
Surgical therapy for chronic obstructive pulmonary disease. Seminars in respiratory and critical care medicine. 2005 Review GET IT
Times cited: 42
Tuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational lung disease, pulmonary infections, and social issues in AJRCCM in 2004. American journal of respiratory and critical care medicine. 2005 Academic Article GET IT
Times cited: 4
Is it asthma or COPD? The answer determines proper therapy for chronic airflow obstruction. Postgraduate medicine. 2005 Review GET IT
Times cited: 15
Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2005 Academic Article GET IT
Times cited: 216
Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. The American journal of pathology. 2005 Academic Article GET IT
Times cited: 111
Cigarette smoking in interstitial lung disease: concepts for the internist. The Medical clinics of North America. 2004 Review GET IT
Times cited: 16
Resting and exercise physiology in interstitial lung diseases. Clinics in chest medicine. 2004 Review GET IT
Times cited: 53
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy. Expert opinion on pharmacotherapy. 2004 Review GET IT
Times cited: 41
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. American journal of respiratory and critical care medicine. 2004 Academic Article GET IT
Times cited: 492
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. American journal of respiratory and critical care medicine. 2004 Academic Article GET IT
Times cited: 41
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. The American journal of pathology. 2004 Academic Article GET IT
Times cited: 61
Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2004 Academic Article GET IT
Times cited: 28
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia. Journal of clinical pathology. 2004 Academic Article GET IT
Times cited: 51
Acute bronchitis: state of the art diagnosis and therapy. Comprehensive therapy. 2004 Review GET IT
Times cited: 18
Clinical implications of macrolide therapy in chronic sinopulmonary diseases. Current pharmaceutical design. 2004 Review GET IT
Times cited: 13
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs. 2004 Review GET IT
Times cited: 230
Mechanisms of pulmonary fibrosis. Annual review of medicine. 2004 Review GET IT
Times cited: 560
Advances in critical care hepatology. American journal of respiratory and critical care medicine. 2003 Review GET IT
Times cited: 37
Patient selection for lung volume reduction surgery. Chest surgery clinics of North America. 2003 Review GET IT
Times cited: 9
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. American journal of respiratory and critical care medicine. 2003 Academic Article GET IT
Times cited: 430
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. American journal of respiratory and critical care medicine. 2003 Academic Article GET IT
Times cited: 434
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. American journal of respiratory and critical care medicine. 2003 Academic Article GET IT
Times cited: 225
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003 Academic Article GET IT
Times cited: 460
A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Molecular medicine (Cambridge, Mass.). 2003 Academic Article GET IT
Times cited: 34
Thoracic transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2003 Review GET IT
Times cited: 19
Informal caregiving for chronic lung disease among older Americans. Chest. 2002 Academic Article GET IT
Times cited: 37
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002 Review GET IT
Times cited: 128
Clinical significance of histological classification of idiopathic interstitial pneumonia. The European respiratory journal. 2002 Academic Article GET IT
Times cited: 319
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. American journal of respiratory and critical care medicine. 2002 Conference Paper GET IT
Times cited: 3436
Pulmonary function tests in interstitial lung disease: what role do they have?. Clinics in chest medicine. 2001 Review GET IT
Times cited: 60
Histopathologic variability in usual and nonspecific interstitial pneumonias. American journal of respiratory and critical care medicine. 2001 Academic Article GET IT
Times cited: 579
Prognostication in chronic obstructive pulmonary disease: implications for lung transplantation. Seminars in respiratory and critical care medicine. 2001 Academic Article GET IT
Times cited: 17
Timing of lung transplantation for patients with fibrotic lung diseases. Seminars in respiratory and critical care medicine. 2001 Academic Article GET IT
Times cited: 9
Nonspecific interstitial pneumonia (NSIP). Seminars in respiratory and critical care medicine. 2001 Academic Article GET IT
Times cited: 29
Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. American journal of respiratory and critical care medicine. 2001 Academic Article GET IT
Times cited: 81
Usual interstitial pneumonia. Seminars in respiratory and critical care medicine. 2001 Academic Article GET IT
Times cited: 22
Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. Chest. 2001 Academic Article GET IT
Times cited: 105
Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. The European respiratory journal. 2001 Academic Article GET IT
Times cited: 235
Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy. Clinical therapeutics. 2001 Academic Article GET IT
Times cited: 29
Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. The American journal of medicine. 2001 Academic Article GET IT
Times cited: 162
The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy. Postgraduate medicine. 2001 Review GET IT
Times cited: 22
Diagnosing interstitial lung disease: a practical approach to a difficult problem. Cleveland Clinic journal of medicine. 2001 Review GET IT
Times cited: 4
Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest. 2001 Review GET IT
Times cited: 209
Lung volume reduction surgery for emphysema. Clinics in chest medicine. 2000 Review GET IT
Times cited: 39
The role of pulmonary function testing in pulmonary fibrosis. Current opinion in pulmonary medicine. 2000 Review GET IT
Times cited: 27
Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids. Chest. 2000 Academic Article GET IT
Times cited: 98
Differential diagnosis of chronic airflow obstruction. The Journal of asthma : official journal of the Association for the Care of Asthma. 2000 Review GET IT
Times cited: 14
Tuberculous pneumonia complicating lung transplantation: case report and review of the literature. 2000 GET IT
Times cited: 8
Weight gain after lung volume reduction surgery is not correlated with improvement in pulmonary mechanics. Chest. 1999 Academic Article GET IT
Times cited: 20
Dobutamine stress echocardiography for the preoperative evaluation of patients undergoing lung volume reduction surgery. The Journal of thoracic and cardiovascular surgery. 1999 Academic Article GET IT
Times cited: 18
Respiratory response during arm elevation in isolated diaphragm weakness. American journal of respiratory and critical care medicine. 1999 Academic Article GET IT
Times cited: 11
Endocrinologic and metabolic complications in the intensive care unit. Clinics in chest medicine. 1999 Review GET IT
Times cited: 8
Preoperative echocardiographic evaluation of patients referred for lung volume reduction surgery. Chest. 1998 Academic Article GET IT
Times cited: 44
Community-acquired pneumonia. Current opinion in pulmonary medicine. 1998 Review GET IT
Times cited: 32
Diagnosing chronic obstructive pulmonary disease. The importance of differentiating asthma, emphysema, and chronic bronchitis. Postgraduate medicine. 1998 Review GET IT
Times cited: 13
Idiopathic pulmonary fibrosis: predicting response to therapy and survival. American journal of respiratory and critical care medicine. 1998 Academic Article GET IT
Times cited: 381
Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD. Chest. 1997 Academic Article GET IT
Times cited: 41
Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. The Annals of thoracic surgery. 1997 Academic Article GET IT
Times cited: 60
Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR. American journal of roentgenology. 1997 Academic Article GET IT
Times cited: 402
Pulmonary smooth muscle proliferation occurring after lung transplantation. 1997 GET IT
Times cited: 8
Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. American journal of respiratory and critical care medicine. 1997 Academic Article GET IT
Times cited: 287
Accessory cardiac bronchus presenting with haemoptysis. 1997 GET IT
Times cited: 15
Arm training reduces the VO2 and VE cost of unsupported arm exercise and elevation in chronic obstructive pulmonary disease. Journal of cardiopulmonary rehabilitation. 1997 Academic Article GET IT
Times cited: 55
Lung mechanics and dyspnea after lung transplantation for chronic airflow obstruction. American journal of respiratory and critical care medicine. 1996 Academic Article GET IT
Times cited: 27
Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy. American journal of respiratory and critical care medicine. 1996 Academic Article GET IT
Times cited: 154
Familial association of primary pulmonary hypertension and a new low-oxygen affinity beta-chain hemoglobinopathy, Hb Washtenaw. 1996 GET IT
Times cited: 11
Transthoracic needle aspiration in patients with severe emphysema. A study of lung transplant candidates. Chest. 1996 Academic Article GET IT
Times cited: 38
Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease. The Annals of thoracic surgery. 1995 Academic Article GET IT
Times cited: 34
The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. 1995 GET IT
Times cited: 121
Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. American journal of respiratory and critical care medicine. 1995 Academic Article GET IT
Times cited: 38
Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest. 1995 Academic Article GET IT
Times cited: 59
Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest. 1994 Review GET IT
Times cited: 80
Increased resistance of hygroscopic condenser humidifiers when using a closed circuit suction system. 1994 GET IT
Times cited: 5
Limitations of spirometry in detecting rejection after single-lung transplantation. American journal of respiratory and critical care medicine. 1994 Academic Article GET IT
Times cited: 55
Dyspnea and tracheal mass in an elderly man. 1994 GET IT
Times cited: 11
Pulmonary function in single lung transplantation for chronic obstructive pulmonary disease. The Journal of thoracic and cardiovascular surgery. 1994 Academic Article GET IT
Times cited: 26
Dyspnea in a patient years after severe poliomyelitis. The role of cardiopulmonary exercise testing. 1994 GET IT
Times cited: 7
Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest. 1994 Academic Article GET IT
Times cited: 98
Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with severe chronic airflow obstruction. Chest. 1993 Academic Article GET IT
Times cited: 103
Diagnosis of unilateral mainstem bronchial obstruction following single-lung transplantation with routine spirometry. 1993 GET IT
Times cited: 18
Pulmonary rehabilitation that includes arm exercise reduces metabolic and ventilatory requirements for simple arm elevation. Chest. 1993 Academic Article GET IT
Times cited: 85
Spontaneous hemothorax. Report of 6 cases and review of the literature. Medicine. 1992 Review GET IT
Times cited: 74
The unresponsive asthmatic. Misuse of a spacer system. Chest. 1992 Letter GET IT
Shoulder pain, pleural effusion, and positive antinuclear, antibodies in a man. 1992 GET IT
Respiratory response and ventilatory muscle recruitment during arm elevation in normal subjects. Chest. 1992 Academic Article GET IT
Times cited: 61
Upper lobe cavitary mass in a steroid-dependent asthmatic patient. 1991 GET IT
Times cited: 1
Intrathoracic lymphadenopathy. A rare manifestation of rheumatoid pulmonary disease. 1990 GET IT
Times cited: 10
Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest. 1989 Academic Article GET IT
Times cited: 73
Chromobacterium violaceum as a cause of periorbital cellulitis. 1984 GET IT
Times cited: 13

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Multidisciplinary Approach Training in Respiratory Research awarded by National Heart, Lung, & Blood Institute Principal Investigator 2023 - 2028
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients awarded by National Heart, Lung, & Blood Institute Principal Investigator 2022 - 2026
SubAward for Institution # 204296-Project 3 awarded by Sponsor Creation Pending Principal Investigator 2021 - 2026
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study awarded by National Heart, Lung, & Blood Institute Principal Investigator 2021 - 2026
Understanding the Origins of Early COPD awarded by National Heart, Lung, & Blood Institute Principal Investigator 2020 - 2025
The CAPTURE Study: Validating a unique COPD screening tool in primary care awarded by COPD Foundation, Inc. Principal Investigator 2018 - 2024
Multidisciplinary Approach Training in Respiratory Research awarded by National Heart, Lung, & Blood Institute Principal Investigator 2018 - 2023
The CAPTURE Study: Validating a Unique COPD Screening Tool in Primary Care awarded by National Heart, Lung, & Blood Institute Principal Investigator 2017 - 2023

Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers awarded by National Heart, Lung, & Blood Institute Co-Investigator 2021 - 2026
Development of a Stakeholder Engaged Intervention to Improve Knowledge and Health-Related Quality of Life in SSc-ILD awarded by Scleroderma Foundation Co-Investigator 2022 - 2025
The Human Distal Airway Aging Project awarded by National Heart, Lung, & Blood Institute Co-Investigator 2019 - 2023

1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial awarded by National Heart, Lung, & Blood Institute Key Personnel 2021 - 2026

SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression awarded by National Institute of Mental Health Principal Investigator Subaward 2017 - 2024

more ...

less ...

Background

education and training

M.S., University of Michigan School of Public Health 2001
M.D., University of Florida College of Medicine 1983
B.S., University of Florida 1980

Contact

full name

Fernando J Martinez

primary email

fjm2003@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Fernando J Martinez Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage